• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CYCCP

CYCCP

Cyclacel Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD5.05

-0.23 (-4.36%)

Company Profile

CEO

Sing Ee Wong

IPO Date

2005-11-30

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$5.35

Prev. Close

$5.28

Day Low

$5.05

Day High

$5.43

52W Low

$3.29

52W High

$17.00

Market Cap

$0.01B

Volume

0.01M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

17.3%

Avg Negative

5.9%

Avg Neutral

76.8%

News Feed

Cyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/11/2021·↓ negative

Cyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/12/2021·↓ negative

Cyclacel to Present at the Oppenheimer 31st Annual Healthcare Conference

GlobeNewsWire·3/15/2021·↑ positive

Cyclacel Pharmaceuticals Presses Capital Raise Button

Benzinga·3/12/2021·↑ positive

Cyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·2/25/2021·↓ negative

Cyclacel Pharmaceuticals Reviews 2020 Achievements and Announces Key Business Objectives for 2021

GlobeNewsWire·1/11/2021·↑ positive

Cyclacel Pharmaceuticals to Present at Biotech Showcase™ Digital 2021

GlobeNewsWire·12/30/2020·↑ positive

Cyclacel Pharmaceuticals' (CYCC) CEO Spiro Rombotis on Q3 2020 Results - Earnings Call Transcript

Seeking Alpha·11/11/2020·↓ negative

Cyclacel Pharmaceuticals to Release Third Quarter Financial Results

GlobeNewsWire·11/5/2020·↑ positive

Cyclacel Presents Phase 1 Clinical Data Showing Safety, Anti-Tumor Activity and Good Oral Bioavailability of Fadraciclib in Patients With Advanced Solid Tumors at the EORTC-NCI-AACR Symposium 2020

GlobeNewsWire·10/26/2020·↑ positive